¼¼°èÀÇ ¾È³» ·»Áî ½ÃÀå
Intraocular Lenses
»óǰÄÚµå : 1514105
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 266 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,260,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,780,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¾È³» ·»Áî ½ÃÀåÀº 2030³â±îÁö 68¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.

2023³â¿¡ 46¾ï ´Þ·¯·Î Æò°¡µÈ ¾È³» ·»Áî ½ÃÀåÀº ¿¹Ãø ±â°£ µ¿¾È º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 5.7%·Î ¼ºÀåÇÒ Àü¸ÁÀ̸ç 2030³â¿¡´Â 68¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀΠǥÁØÇü ¾È³» ·»Áî´Â º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 4.9%·Î ¼ºÀåÀ» Áö¼ÓÇϰí, ºÐ¼® ±â°£ Á¾·á ½Ã 36¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ´Ù±â´É ¾È³» ·»Áî ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 6.7%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 12¾ï ´Þ·¯¸¦ ³ªÅ¸³¾ Àü¸ÁÀ̸ç Áß±¹Àº º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 8.6%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¹Ì±¹ÀÇ ¾È³» ·»Áî ½ÃÀåÀº 2023³â 12¾ï ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 15¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 8.6%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) °¢°¢ 3.5%¿Í 4.5%·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 4.3%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°è ¾È³» ·»Áî ½ÃÀå-ÁÖ¿ä ÃËÁø¿äÀΰú µ¿Çâ Á¤¸®

¾È³» ·»Áî´Â ¹é³»Àå ¹× ±âŸ ³ëÈ­¿Í °ü·ÃµÈ ¾È±¸ ÁúȯÀÇ ¼¼°è À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Å« ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù. Àα¸ÀÇ °í·ÉÈ­¿Í ½Ã·Â °Ç°­¿¡ ´ëÇÑ ÀǽÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¹é³»Àå ¼ö¼ú°ú ¼öÁ¤Ã¼ ġȯ¼ú ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ÀÌ ¼ö¿ä´Â Á¤ºÎ¿Í ºñ¿µ¸® ´ÜüÀÇ ÀÌ´Ï¼ÅÆ¼ºê¿¡ ÀÇÇØ ´õ¿í °­È­µÇ°í ÀÖ½À´Ï´Ù. ÀÇ·á ÀÎÇÁ¶ó°¡ Á¤ºñµÇ¾î ¼ö¼ú ¹æ¹ýÀÌ °³¼±µÊÀ¸·Î½á, ÀÌ·¯ÇÑ Ä¡·á°¡ º¸´Ù Ä£¼÷ÇØÁö°í, ¾È³» ·»ÁîÀÇ ²ÙÁØÇÑ º¸±Þ¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

¾È³» ·»ÁîÀÇ ºÎ¹®Àº ƯÈ÷ ³ë¾È Ä¡·á¿¡¼­ ±Þ¼ÓÇÑ Áøº¸¸¦ ÀÌ·ç°í ÀÖÀ¸¸ç ȯÀÚÀÇ ¿¹ÈÄ¿Í ¸¸Á·µµ¸¦ Çâ»ó½Ãų °ÍÀ¸·Î ±â´ëµÇ°í ÀÖ½À´Ï´Ù. ÃÖ±Ù ±â¼ú Çõ½ÅÀº ´ÙÃÊÁ¡ ¾È³» ·»Áî, ¼ö¿ëÇü ¾È³» ·»Áî, ÇÉȦ ¾È³» ·»Áî, ÃÊÁ¡ ½Éµµ È®´ë ¾È³» ·»Áî µîÀÇ ±â¼úÀ» ÅëÇØ ȯÀÚÀÇ ±¤¹üÀ§ÇÑ ¿ä±¸¿¡ ´ëÀÀÇÏ´Â µ¥ ÁßÁ¡À» µÓ´Ï´Ù. ÀÌ·¯ÇÑ Áøº¸´Â ¾È°æ ÀÇÁ¸À» ¿ÏÈ­ÇÏ°í ³ë¾ÈÀ» ¾Î°íÀÖ´Â »ç¶÷µéÀÇ »îÀÇ ÁúÀ» Çâ»ó½ÃŰ´Â ¹æ¹ýÀ» ¼³¸íÇÕ´Ï´Ù. »õ·Î¿î ¾È³» ·»Áî ±â¼úÀº ȯÀÚ¿¡ ¸Â´Â °á°ú¿¡ ÁßÁ¡À»µÎ°í °³¹ßµÇ¾ú½À´Ï´Ù. ÀÌ Á¢±Ù¹ýÀº °³º° ¸ñÇ¥¸¦ ´õ Àß ÀÌÇØÇϰí ÇØ°áÇϱâ À§ÇØ È¯ÀÚ°¡ º¸°íÇÏ´Â QOL ÁöÇ¥¸¦ ÅëÇÕÇÏ´Â Á¾ÇÕÀûÀÎ ÀÓ»ó½ÃÇèÀ» Æ÷ÇÔÇÕ´Ï´Ù. ´ÙÃÊÁ¡ ·»Áî, Å丯 ·»Áî, ¼ö¿ë ·»Áî µîÀÇ ÇÁ¸®¹Ì¾ö ¾È³» ·»Áî´Â ¿©·¯ ½Ã·Â ¹®Á¦¸¦ µ¿½Ã¿¡ ÇØ°áÇÏ°í ¼ö¼ú ÈÄ È¯ÀÚÀÇ Àü¹ÝÀûÀÎ »îÀÇ ÁúÀ» Çâ»ó½Ãų ¼ö Àֱ⠶§¹®¿¡ Àα⸦ ¾ò°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ·»Áî´Â ¾È°æ¿¡ ´ëÇÑ ÀÇÁ¸¼ºÀ» ÁÙÀÌ°í ³­½Ã¸¦ ±³Á¤ÇÏ´Â µîÀÇ ÀåÁ¡ÀÌ Àֱ⠶§¹®¿¡ Á¾ÇÕÀûÀÎ ½Ã°¢ ¼Ö·ç¼ÇÀ» ¿ä±¸Çϴ ȯÀÚ¿¡°Ô ¼±È£µË´Ï´Ù. °Ô´Ù°¡, Àç·á¿Í ·»Áî ÄÚÆÃÀÇ Áøº¸·Î ¼ö¼ú ÈÄ ÇÕº´ÁõÀÌ Å©°Ô ÁÙ¾îµé°í, ¾È³» ·»ÁîÀÇ ³»±¸¼º°ú ÀûÇÕ¼ºÀÌ Çâ»óµÇ¾î ½ÃÀåÀÇ ¸Å·ÂÀÌ ´õ¿í ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. Áö¼ÓÀûÀÎ ±â¼úÀÇ ¹ßÀü°ú ½Ã°¢ Àå¾ÖÀÇ °¨¼Ò´Â »õ·Î¿î °í±Þ ¾È³» ·»Áî°¡ ȯÀÚÀÇ ±â´ë¸¦ ÀçÁ¤ÀÇÇÒ °¡´É¼ºÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ¼ÒºñÀÚÀÇ ±â´ë º¯È­¿Í ³·Àº ħ½ÀÀ¸·Î Á¤¹ÐÇÑ ¿Ü°úÀû °³ÀÔÀ» ¿ä±¸ÇÏ´Â µ¿ÇâÀÌ ¾È°ú ÀÇ»ç¿Í Ŭ¸®´Ð¿¡ Çõ½ÅÀûÀÎ ±â¼úÀ» äÅÃÇϵµ·Ï Ã˱¸Çϰí ÀÖ½À´Ï´Ù. ÆèÅä ¼¼ÄÁµå ·¹ÀÌÀú¸¦ »ç¿ëÇÏ¿© Á¤¹ÐÇÑ Àý°³¸¦ ½Ç½ÃÇÏ´Â ÆèÅä ¹é³»Àå ¼ö¼úÀÇ ÀαⰡ ³ô¾ÆÁö°í ÀÖ¾î °íµµÀÇ ¾È³» ·»ÁîÀÇ Á¤È®ÇÑ À̽ÄÀÌ °¡´ÉÇØÁö°í ÀÖ½À´Ï´Ù. ÃÖ÷´Ü Áø´Ü µµ±¸¸¦ »ç¿ëÇÒ ¼ö ÀÖ°Ô µÇ¸é °³º° ȯÀÚÀÇ Çʿ信 ¸Â°Ô ·»Á ¼±ÅÃÇÒ ¼ö ÀÖ¾î °í±Þ ¾È³» ·»ÁîÀÇ »ç¿ëÀÌ ÃËÁøµË´Ï´Ù. ±â¼ú°ú Á¢±Ù¼ºÀÌ °è¼Ó °³¼±µÇ°í ÀÖ´Â °¡¿îµ¥, ¾È³» ·»Áî ½ÃÀåÀº ƯÈ÷ °í·ÉÈ­°¡ ÁøÇàµÇ°í ½Ã·Â °³¼±¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ôÀº Áö¿ª¿¡¼­ Áö¼ÓÀûÀÎ ¼ºÀåÀÌ ¿¹»óµÇ°í ÀÖ½À´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ ¿¹(Àü 28°Ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

BJH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Intraocular Lenses Market to Reach US$6.8 Billion by 2030

The global market for Intraocular Lenses estimated at US$4.6 Billion in the year 2023, is expected to reach US$6.8 Billion by 2030, growing at a CAGR of 5.7% over the analysis period 2023-2030. Standard Intraocular Lenses, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$3.6 Billion by the end of the analysis period. Growth in the Premium Intraocular Lenses segment is estimated at 6.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 8.6% CAGR

The Intraocular Lenses market in the U.S. is estimated at US$1.2 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2030 trailing a CAGR of 8.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 4.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Intraocular Lenses Market - Key Drivers and Trends Summarized

Intraocular lenses (IOLs) have seen significant growth due to the rising prevalence of cataracts and other age-related eye conditions globally. With an aging population and increased awareness about vision health, the demand for cataract surgeries and lens replacements has surged. This demand is further bolstered by governmental and non-profit initiatives to reduce the global burden of avoidable blindness, particularly in low and middle-income regions. The growing healthcare infrastructure and improvements in surgical procedures have also made such treatments more accessible, contributing to the steady adoption of intraocular lenses.

The field of intraocular lenses (IOLs) is experiencing rapid advancements, particularly in presbyopia treatment, offering hope for improved patient outcomes and satisfaction. Recent innovations focus on accommodating a wide array of patient needs through technology such as multifocal, accommodating, pinhole, and extended-depth-of-focus IOLs. These advancements provide a pathway to reducing spectacle dependence and improving the quality of life for people affected by presbyopia. New IOL technology is being developed with an emphasis on personalized patient outcomes. This approach includes comprehensive clinical trials that integrate patient-reported quality-of-life measures to better understand and address individual goals. Premium IOLs, such as multifocal, toric, and accommodating lenses, have gained popularity due to their ability to address multiple vision issues simultaneously, improving patients' overall quality of life post-surgery. These lenses offer benefits like reducing the dependence on glasses and correcting astigmatism, making them a preferred choice among patients seeking comprehensive visual solutions. Moreover, advances in materials and lens coatings have significantly reduced postoperative complications and enhanced the durability and compatibility of IOLs, further boosting their market appeal. The continued technological advancements and reduced visual disturbances underscore the potential of new premium IOLs to redefine patient expectations.

Additionally, changing consumer expectations and trends toward minimally invasive and precise surgical interventions have spurred ophthalmologists and clinics to adopt innovative techniques. Femto-cataract surgery, which uses femtosecond lasers for precise incisions, is becoming increasingly popular, enabling the accurate implantation of sophisticated IOLs. The growing availability of cutting-edge diagnostic tools helps to tailor lens selection to individual patient needs, encouraging the use of advanced IOLs. As technology and accessibility continue to improve, the intraocular lens market is poised for continued growth, especially in regions with aging populations and high demand for improved vision health.

Select Competitors (Total 28 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â